Abattis Rebrands as a Downstream Solutions Provider for the Cannabis Market
Mar 06, 2018 13:31 pm UTC| Business
VANCOUVER, British Columbia, March 06, 2018 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has officially rebranded itself as a one-stop provider of downstream...
Relievant Appoints Christopher Geyen Chief Financial Officer
Mar 06, 2018 13:31 pm UTC| Business
SUNNYVALE, Calif., March 06, 2018 -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of...
Corvus Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference 2018
Mar 06, 2018 13:31 pm UTC| Business
BURLINGAME, Calif., March 06, 2018 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies,...
CHF Solutions to Attend the 30th Annual Roth Conference
Mar 06, 2018 13:31 pm UTC| Business
EDEN PRAIRIE, Minn., March 06, 2018 -- CHF Solutions (Nasdaq:CHFS), today announces that it will attend the 30th Annual Roth Conference and meet one-on-one with investors. The company will meet with investors...
Fusion to Present at the 30th Annual ROTH Conference
Mar 06, 2018 13:31 pm UTC| Business
NEW YORK, March 06, 2018 -- Fusion (NASDAQ:FSNN), a leading provider of cloud services, announced today that Matthew Rosen, its Chief Executive Officer, will present at the 30th Annual ROTH Conference on Tuesday, March...
Exela Technologies Unveils New York Innovation Center
Mar 06, 2018 13:31 pm UTC| Business
IRVING, Texas, March 06, 2018 -- Exela Technologies, Inc. (“Exela”) (NASDAQ:XELA), one of the largest global providers of digital platforms for Business Process Automation (“BPA”), today announced the unveiling of its...
Onconova Therapeutics to Present at the 30th Annual Roth Conference in March
Mar 06, 2018 13:31 pm UTC| Business
NEWTOWN, Pa., March 06, 2018 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...